SAB Biotherapeutics (SABS) Interest Expenses (2021 - 2026)
SAB Biotherapeutics (SABS) reported Interest Expenses of $62,000 for Q2 2026, down 3.1% from $64,000 a year earlier and down 1.2% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Interest Expenses (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, SAB Biotherapeutics' Interest Expenses came in at $231,499, down 18.0% year-over-year; for FY2025, it was $240,664, down 24.4% from FY2024.
- Interest Expenses has a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
- By year, Interest Expenses came in at $318,401 in FY2024 (+1.0%), $315,284 in FY2023 (+4.5%), $301,584 in FY2022 (+2.4%) and $294,459 in FY2021 (-37.2%).
- Five-year quarterly Interest Expenses spans a low of $43,292 in Q3 2025 and a high of $93,119 in Q2 2024.
- Year over year, Interest Expenses has now declined in each of the last seven quarters, with an average decline of 13.1% over the last eight quarters.
- The high point for year-over-year Interest Expenses in five years was Q4 2022 (growth of 32.3%); the low point was Q3 2025 (a decline of 44.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $62,745 (Q1 2026), $63,462 (Q4 2025) and $43,292 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | SAB Biotherapeutics | 279.79 Mn | -130.87 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62,000.00 |
| Mar 31, 2026 | 62,745.00 |
| Dec 31, 2025 | 63,462.00 |
| Sep 30, 2025 | 43,292.00 |
| Jun 30, 2025 | 64,000.00 |
| Mar 31, 2025 | 69,565.00 |
| Dec 31, 2024 | 70,876.00 |
| Sep 30, 2024 | 78,036.00 |
| Jun 30, 2024 | 93,119.00 |
| Mar 31, 2024 | 76,371.00 |
| Dec 31, 2023 | 77,879.00 |
| Sep 30, 2023 | 69,700.00 |
| Jun 30, 2023 | 75,320.00 |
| Mar 31, 2023 | 92,385.00 |
| Dec 31, 2022 | 87,699.00 |
| Sep 30, 2022 | 70,626.00 |
| Jun 30, 2022 | 71,237.00 |
| Mar 31, 2022 | 72,022.00 |
| Dec 31, 2021 | 66,275.00 |
| Sep 30, 2021 | 78,558.00 |
API Access
SAB Biotherapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();